Letters to the Editor

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation

Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Medical Clinic and Polyclinic 1, Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany; Cancer Center Central Germany, Leipzig
Haematologica Early view Aug 13, 2026 https://doi.org/10.3324/haematol.2026.301225